Tivic Health Systems, Inc. (TIVC) - Dilution Analysis

S-1 filing: This prospectus relates to the offer and resale by Tumim Stone Capital, LLC of up to an aggregate of 956,222 shares of common stock of Tivic Health Systems, Inc., consisting of shares that may be sold to Tumim pursuant to a Common Stock Purchase Agreement and shares issuable upon exercise of a pre-funded warrant.

10-K filing | 2.5M shares outstanding

S-3 filing: This prospectus relates to the offer and resale by the selling stockholders of up to 36,135,295 shares of common stock of Tivic Health Systems, Inc., consisting of shares issuable upon conversion of Series C Preferred Stock and shares issuable upon exercise of warrants.

S-3 filing: This prospectus relates to the offer and resale from time to time of up to 13,659,638 shares of common stock of Tivic Health Systems, Inc. by 3i, LP.

8-K filing: Tivic Health Systems, Inc. entered into a Securities Purchase Agreement with 3i to issue a senior secured convertible note and a warrant to purchase common stock, and also entered into a Securities Purchase Agreement with certain institutional investors to sell Series C Non-Voting Convertible Preferred Stock and warrants to purchase shares of Common Stock. ($75.0M proceeds)

10-Q filing | 1.7M shares outstanding

10-Q filing | 1.1M shares outstanding

S-3 filing: This prospectus relates to the offer and resale by Helena Global Investment Opportunities 1 Ltd. of up to 605,023 shares of common stock of Tivic Health Systems, Inc., consisting of shares issuable upon conversion of Series B Preferred Stock and shares issuable upon exercise of warrants.

S-3 filing: This S-3 filing from 2025-08-08 details the offering of up to 400,044 shares of common stock for resale by selling stockholders.

S-1 filing: This prospectus relates to the offer and resale by Helena Global Investment Opportunities 1 Ltd. of up to 8,438,949 shares of common stock of Tivic Health Systems, Inc.

10-Q filing | 0.9M shares outstanding

S-1 filing: This S-1 filing relates to the offer and resale by Mast Hill Fund, L.P. of up to 292,523 shares of common stock of Tivic Health Systems, Inc., consisting of shares that may be sold to Mast Hill under an Equity Purchase Agreement and commitment shares issued to Mast Hill.

8-K filing: Tivic Health Systems, Inc. entered into a Securities Purchase Agreement to sell up to 8,400 shares of Series B Non-Voting Convertible Preferred Stock and warrants for up to $8,400,000 in several tranches, with Craft Capital Management LLC acting as placement agent. ($8.4M proceeds)

8-K filing: Tivic Health Systems, Inc. entered into an Equity Purchase Agreement with Mast Hill Fund, L.P., for the sale of up to $25,000,000 of the Company's common stock over 24 months, and issued 29,800 restricted shares of common stock to the Investor as a commitment fee.

10-K filing | 0.6M shares outstanding

8-K filing: Stock split 1-for-17 | Outstanding: 8,266,085 → 486,240

8-K filing: Tivic Health Systems, Inc. entered into an exclusive license agreement with Statera Biopharma, Inc. and issued shares of common stock and Series A Preferred Stock to Statera for an aggregate price of approximately $1.2 million. ($2.4M proceeds)

10-Q filing | 8.3M shares outstanding

10-Q filing | 6.2M shares outstanding

10-Q filing | 6.2M shares outstanding

S-1/A filing: This is an S-1/A filing for an offering of common stock, pre-funded warrants, and common warrants with Maxim Group LLC as the exclusive placement agent.

S-1/A filing: This S-1/A filing registers for sale shares of common stock, common warrants, pre-funded warrants and placement agent warrants.

S-1 filing: The company is offering shares of common stock, common warrants, and pre-funded warrants on a best efforts basis with Maxim Group LLC as the exclusive placement agent.

10-K filing | 1.5M shares outstanding

10-Q filing | 1.5M shares outstanding

8-K filing: Stock split 1-for-100 | Outstanding: 146,600,734 → 1,466,007

10-Q filing | 146.6M shares outstanding

8-K filing: Tivic Health Systems, Inc. completed a public offering of 33,173,000 shares of common stock at $0.041 per share, resulting in gross proceeds of approximately $1.4 million. ($1.4M proceeds)

8-K filing: Tivic Health Systems, Inc. completed an offering of 51,250,000 shares of common stock at a price of $0.040 per share, resulting in gross proceeds of approximately $2.1 million. ($2.1M proceeds)

8-K filing: Tivic Health Systems, Inc. completed an offering of 32,500,000 shares of common stock at a price of $0.055 per share, resulting in gross proceeds of approximately $1.8 million and net proceeds of approximately $1.6 million, which the company intends to use for working capital and general corporate purposes. ($1.8M proceeds)

8-K filing: On June 14, 2023, the Company's Board granted each of the non-executive members of the Board stock options to purchase 25,000 shares of Company common stock at an exercise price of $0.093 per share.

10-Q filing | 29.7M shares outstanding

10-K filing | 29.7M shares outstanding

8-K filing: Tivic Health Systems, Inc. completed a public offering of 20,000,000 shares of common stock at $0.25 per share, resulting in gross proceeds of $5.0 million. ($5.0M proceeds)

S-3 filing: The company is filing an S-3 to offer up to $100,000,000 in various securities, including common stock, preferred stock, debt securities, warrants, subscription rights, and units.

S-1/A filing: This is an S-1/A filing for a company offering common stock and pre-funded warrants.

S-1/A filing: Tivic Health Systems, Inc. is offering 18,320,610 shares of common stock and pre-funded warrants to purchase 18,320,610 shares of common stock.

S-1/A filing: Tivic Health Systems, Inc. is offering up to 15,094,339 shares of common stock and pre-funded warrants to purchase up to 15,094,339 shares of common stock.

S-1/A filing: The filing is an S-1/A amendment for an offering of common stock, with an option to purchase additional shares.

10-Q filing | 9.7M shares outstanding

S-1 filing: This S-1 filing relates to an offering of common stock with an option to purchase additional shares and warrants to be issued to the underwriter.

10-Q filing | 9.6M shares outstanding

10-Q filing | 9.7M shares outstanding

8-K filing: Tivic Health Systems, Inc. consummated the Underwriter's exercise of the Overallotment Option on November 18, 2021, resulting in gross proceeds of $2,250,000 to the Company. Additionally, they entered into a sublease agreement for office space in Hayward, California. ($17.25M proceeds)

8-K filing: Tivic Health Systems, Inc. consummated its initial public offering of 3,000,000 shares of its common stock at a public offering price of $5.00 per share, generating gross proceeds of $15,000,000. ($15.0M proceeds)

S-1/A filing: This is a firm commitment initial public offering of 2,727,272 shares of common stock of Tivic Health Systems, Inc. We anticipate that the initial public offering price of our shares will be between $5.00 and $6.00.

S-1/A filing: This is a firm commitment initial public offering of 2,727,272 shares of common stock of Tivic Health Systems, Inc. We anticipate that the initial public offering price of our shares will be between $5.00 and $6.00.

S-1/A filing: This is a firm commitment initial public offering of 2,727,272 shares of common stock of Tivic Health Systems, Inc.

S-1/A filing: This is a firm commitment initial public offering of shares of common stock of Tivic Health Systems, Inc.